10x Genomics, Inc. — Director's Dealing 2022

Sep 16, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2022-09-14

Reporting Person: Kosaraju Sridhar (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-09-14	Class A Common Stock	M	10000	$11.48	Acquired	30578	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-09-14	Stock Option (right to buy)	$11.48	M	10000	Disposed	2029-05-10	Class A Common Stock (10000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Common Stock	3000	Indirect

Footnotes

F1: These shares are held by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee.

F2: This option, originally for 130,000 shares, of which 45,833 have been exercised, vested as to one forty-eighth of the shares on April 29, 2019, and one-forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. This option may be exercised prior to vesting, subject to the Issuer's right to repurchase unvested shares.